Arthritis Research & Therapy

official impact factor 4.36

Open Access Email this article to a friend

Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis

Larry Moreland*, Ron Gugliotti, Kevin King, Walter Chase, Michael Weisman, Thomas Greco, Rose Fife, Joseph Korn, Robert Simms, John Tesser, Jan Hillson, Jacques Caldwell, Thomas Schnitzer, David Lyons and Ullrich Schwertschlag

Arthritis Res 2001, 3:247-252 doi:10.1186/ar309

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.